EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hsa_circ_0057105 modulates a balance of epithelial‐mesenchymal transition and ferroptosis vulnerability in renal cell carcinoma

Junjie Cen, Yanping Liang, Zihao Feng, Xu Chen, Jinlong Chen, Yinghan Wang, Jiangquan Zhu, Quanhui Xu iD, Guannan Shu, Wenbin Zheng, Hui Liang, Zhu Wang und 5 weitere

Clinical and Translational Medicine · 2023

DOI: 10.1002/ctm2.1339 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Medicine, 2023. Verfasst von Junjie Cen und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Ferroptosis, MicroRNAs, Kidney Neoplasms. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The incidence of renal cell carcinoma (RCC) has increased in recent years. Metastatic RCC is common and remains a major cause of mortality. A regulatory role for circular RNAs (circRNAs) in the occurrence and progression of RCC has been identified, but their function, molecular mechanisms, and potential clinical applications remain poorly understood.

Methods

High‐throughput RNA sequencing was used to explore the differential expression of circRNAs and their related pathways in RCC patients. Transwell and CCK‐8 assays were used to assess the function of hsa_circ_0057105 in RCC cells. The clinical relevance of hsa_circ_0057105 was evaluated in a cohort of RCC patients. The hsa_circ_0057105 regulatory axis was defined using RNA pull‐down, luciferase reporter assays, and fluorescence in situ hybridization assays, and the in vivo effect of hsa_circ_0057105 was validated using animal experiments.

Results

Single‐sample gene set enrichment analysis and correlation analysis of RNA‐seq data showed that hsa_circ_0057105 was potentially oncogenic and may serve to regulate epithelial‐mesenchymal transition (EMT) activation in RCC. Hsa_circ_0057105 expression was associated with advanced TNM stages and was an independent prognostic factor for poor RCC patient survival. Phenotypic studies show that hsa_circ_0057105 can enhance the migration and invasion abilities of RCC cells. Further, hsa_circ_0057105 was shown to inhibit the expression of miR‐577, a miRNA that regulated the expression of both COL1A1, which induced EMT activation, and VDAC2, which modulated ferroptosis sensitivity. The dual regulatory roles of hsa_circ_0057105 on EMT and ferroptosis sensitivity were verified using rescue experiments. Animal studies confirmed that hsa_circ_0057105 increased the metastatic ability and ferroptosis sensitivity of RCC cells in vivo.

Conclusions

In RCC, hsa_circ_0057105 regulates COL1A1 and VDAC2 expression through its sponge effect on miR‐577, acting like a ‘double‐edged sword’. These findings provide new insight into the relationship between EMT and ferroptosis in RCC and provide potential biomarkers for RCC surveillance and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellFerroptosisMicroRNAsKidney NeoplasmsAnimalsRNA, CircularEpithelial-Mesenchymal TransitionIn Situ Hybridization, Fluorescence

Stichwörter der Autor:innen

EMT pathwaycircRNAferroptosisrenal cell carcinoma

Substanzen

RNA, CircularMicroRNAs

Autor:innen und Institutionen

  • Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China.
  • Department of Laboratory Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China.
  • Department of Emergency, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China.
  • Department of Urology, Affiliated Longhua People's Hospital, Southern Medical University, Shenzhen, People's Republic of China.
  • Department of Urology, Jiangmen Central Hospital, Jiangmen, People's Republic of China.
  • Institute of Precision Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China.

ORCID-Profile: Quanhui Xu, Junhang Luo, Yong Huang

Förderung

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation

Zitieren

APA

Cen, J., Liang, Y., Feng, Z., Chen, X., Chen, J., Wang, Y., Zhu, J., Xu, Q., Shu, G., Zheng, W., Liang, H., Wang, Z., Deng, Q., Cao, J., Luo, J., Jin, X., & Huang, Y. (2023). Hsa_circ_0057105 modulates a balance of epithelial‐mesenchymal transition and ferroptosis vulnerability in renal cell carcinoma. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.1339

Vancouver

Cen J, Liang Y, Feng Z, Chen X, Chen J, Wang Y, et al. Hsa_circ_0057105 modulates a balance of epithelial‐mesenchymal transition and ferroptosis vulnerability in renal cell carcinoma. Clinical and Translational Medicine. 2023. doi:10.1002/ctm2.1339

BibTeX
@article{Cen2023,
  author = {Cen, Junjie and Liang, Yanping and Feng, Zihao and Chen, Xu and Chen, Jinlong and Wang, Yinghan and Zhu, Jiangquan and Xu, Quanhui and Shu, Guannan and Zheng, Wenbin and Liang, Hui and Wang, Zhu and Deng, Qiong and Cao, Jiazheng and Luo, Junhang and Jin, Xiaohan and Huang, Yong},
  title = {Hsa_circ_0057105 modulates a balance of epithelial‐mesenchymal transition and ferroptosis vulnerability in renal cell carcinoma},
  journal = {Clinical and Translational Medicine},
  year = {2023},
  doi = {10.1002/ctm2.1339}
}
Kostenlos starten →